A citation-based method for searching scientific literature

Le Liu, Yu-Qing Ni, Jun-Kun Zhan, You-Shuo Liu. Aging Dis 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis.
Narjes Nasiri-Ansari, Chrysa Nikolopoulou, Katerina Papoutsi, Ioannis Kyrou, Christos S Mantzoros, Georgios Kyriakopoulos, Antonios Chatzigeorgiou, Vassiliki Kalotychou, Manpal S Randeva, Kamaljit Chatha,[...]. Int J Mol Sci 2021
13
100

GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.
Hari Hendarto, Toyoshi Inoguchi, Yasutaka Maeda, Noriko Ikeda, Jing Zheng, Ryoko Takei, Hisashi Yokomizo, Eiichi Hirata, Noriyuki Sonoda, Ryoichi Takayanagi. Metabolism 2012
142
100

Glucagon-like peptide-1 receptor agonist stimulates mitochondrial bioenergetics in human adipocytes.
Joanna Góralska, Agnieszka Śliwa, Anna Gruca, Urszula Raźny, Monika Chojnacka, Anna Polus, Bogdan Solnica, Małgorzata Malczewska-Malec. Acta Biochim Pol 2017
13
100

Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure.
Nikole J Byrne, Nobutoshi Matsumura, Zaid H Maayah, Mourad Ferdaoussi, Shingo Takahara, Ahmed M Darwesh, Jody L Levasseur, James Won Suk Jahng, Dyonne Vos, Nirmal Parajuli,[...]. Circ Heart Fail 2020
50
100

Mechanism and application of metformin in kidney diseases: An update.
Anni Song, Chun Zhang, Xianfang Meng. Biomed Pharmacother 2021
2
100

Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity.
Fei Yan, Guang-Hao Zhang, Min Feng, Wei Zhang, Jia-ning Zhang, Wen-qian Dong, Cheng Zhang, Yun Zhang, Li Chen, Ming-Xiang Zhang. Mol Med 2015
24
100

Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease.
Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, Daiji Kawanami, Kazunori Utsunomiya, Rimei Nishimura. Int J Mol Sci 2019
51
100

Liraglutide protects against high-fat diet-induced kidney injury by ameliorating apoptosis.
Riying Liang, Meijun Wang, Chang Fu, Hua Liang, Hongrong Deng, Ying Tan, Fen Xu, Mengyin Cai. Endocr Connect 2020
3
100

Glucagon-Like Peptide-1 Receptor Agonism Improves Nephrotoxic Serum Nephritis by Inhibiting T-Cell Proliferation.
Foteini Moschovaki Filippidou, Alexander H Kirsch, Matthias Thelen, Máté Kétszeri, Katharina Artinger, Ida Aringer, Corinna Schabhüttl, Agnes A Mooslechner, Bianca Frauscher, Marion Pollheimer,[...]. Am J Pathol 2020
10
100

The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
Ya-Kun Li, Dong-Xia Ma, Zhi-Min Wang, Xiao-Fan Hu, Shang-Lin Li, Hong-Zhe Tian, Meng-Jun Wang, Yan-Wen Shu, Jun Yang. Pharmacol Res 2018
25
100

Liraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators.
Robyn Bruen, Seán Curley, Sarina Kajani, Gina Lynch, Marcella E O'Reilly, Eugène T Dillon, Eoin P Brennan, Mary Barry, Stephen Sheehan, Fiona C McGillicuddy,[...]. J Pharmacol Exp Ther 2019
13
100

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
Dick de Zeeuw, Tadao Akizawa, Paul Audhya, George L Bakris, Melanie Chin, Heidi Christ-Schmidt, Angie Goldsberry, Mark Houser, Melissa Krauth, Hiddo J Lambers Heerspink,[...]. N Engl J Med 2013
578
100

Anti-inflammatory effects of exendin-4, a glucagon-like peptide-1 analog, on human peripheral lymphocytes in patients with type 2 diabetes.
Lan He, Chun Kwok Wong, Kitty Kt Cheung, Ho Chung Yau, Anthony Fu, Hai-Lu Zhao, Karen Ml Leung, Alice Ps Kong, Gary Wk Wong, Paul Ks Chan,[...]. J Diabetes Investig 2013
43
100

15
100

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies. Diabetes Care 2020
358
100


Pentraxin-3 regulates the inflammatory activity of macrophages.
Aya Shiraki, Norihiko Kotooka, Hiroshi Komoda, Tetsuaki Hirase, Jun-Ichi Oyama, Koichi Node. Biochem Biophys Rep 2016
32
100


Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation.
Daisuke Shiraishi, Yukio Fujiwara, Yoshihiro Komohara, Hiroshi Mizuta, Motohiro Takeya. Biochem Biophys Res Commun 2012
87
100


Acquisition of the monocyte/macrophage phenotype in human mesangial cells.
S Watanabe, A Yoshimura, K Inui, N Yokota, Y Liu, Y Sugenoya, H Morita, T Ideura. J Lab Clin Med 2001
9
100

Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells.
Laween Uthman, Marius Kuschma, Gregor Römer, Marleen Boomsma, Jens Kessler, Jeroen Hermanides, Markus W Hollmann, Benedikt Preckel, Coert J Zuurbier, Nina C Weber. Cardiovasc Drugs Ther 2021
10
100


Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle-stimulated endothelial senescence and dysfunction: protective effect of gliflozins.
Sin-Hee Park, Eugenia Belcastro, Hira Hasan, Kensuke Matsushita, Benjamin Marchandot, Malak Abbas, Florence Toti, Cyril Auger, Laurence Jesel, Patrick Ohlmann,[...]. Cardiovasc Diabetol 2021
6
100


2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Theresa A McDonagh, Marco Metra, Marianna Adamo, Roy S Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel,[...]. Eur Heart J 2021
139
100

Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes.
Amelia Charlton, Jessica Garzarella, Karin A M Jandeleit-Dahm, Jay C Jha. Biology (Basel) 2020
12
100

The role of incretins and incretin-based drugs in autoimmune diseases.
Shabnam Radbakhsh, Stephen L Atkin, Luis E Simental-Mendia, Amirhossein Sahebkar. Int Immunopharmacol 2021
2
100

Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells.
Jui-Ting Chang, Yao-Jen Liang, Chia-Yu Hsu, Chao-Yi Chen, Po-Jung Chen, Yi-Feng Yang, Yen-Lin Chen, Dee Pei, Jin-Biou Chang, Jyh-Gang Leu. BMC Pharmacol Toxicol 2017
17
100

NAFLD and Chronic Kidney Disease.
Morgan Marcuccilli, Michel Chonchol. Int J Mol Sci 2016
72
100


Partial Epithelial-to-Mesenchymal Transition and Other New Mechanisms of Kidney Fibrosis.
Sara Lovisa, Michael Zeisberg, Raghu Kalluri. Trends Endocrinol Metab 2016
107
100

Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review.
Jason C Kovacic, Stefanie Dimmeler, Richard P Harvey, Toren Finkel, Elena Aikawa, Guido Krenning, Andrew H Baker. J Am Coll Cardiol 2019
164
100

Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease.
Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, Tamotsu Yokota, Kazunori Utsunomiya, Rimei Nishimura. Biomedicines 2020
8
100

18
100



The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential.
Hiroki Fujita, Tsukasa Morii, Hiromi Fujishima, Takehiro Sato, Tatsunori Shimizu, Mihoko Hosoba, Katsushi Tsukiyama, Takuma Narita, Takamune Takahashi, Daniel J Drucker,[...]. Kidney Int 2014
171
100

Empagliflozin ameliorates ethanol-induced liver injury by modulating NF-κB/Nrf-2/PPAR-γ interplay in mice.
Amir Mohamed Abdelhamid, Ahmed Ramadan Elsheakh, Rania Ramadan Abdelaziz, Ghada Mohamed Suddek. Life Sci 2020
5
100

Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.
Raimund Pichler, Maryam Afkarian, Brad P Dieter, Katherine R Tuttle. Am J Physiol Renal Physiol 2017
83
100

Liraglutide relieves myocardial damage by promoting autophagy via AMPK-mTOR signaling pathway in zucker diabetic fatty rat.
Ya Zhang, Yuanna Ling, Li Yang, Yanzhen Cheng, Pingzhen Yang, Xudong Song, Huixiong Tang, Yongkang Zhong, Lu Tang, Shangfei He,[...]. Mol Cell Endocrinol 2017
37
100

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Martina Brueckmann, Anne Pernille Ofstad, Egon Pfarr, Waheed Jamal,[...]. Lancet 2020
251
100

Exendin-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction.
Yen-Ta Chen, Tzu-Hsien Tsai, Chih-Chau Yang, Cheuk-Kwan Sun, Li-Teh Chang, Hung-Hwa Chen, Chia-Lo Chang, Pei-Hsun Sung, Yen-Yi Zhen, Steve Leu,[...]. J Transl Med 2013
73
100

Corrigendum: Safety of Semaglutide.
Mark M Smits, Daniël H Van Raalte. Front Endocrinol (Lausanne) 2021
1
100


Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease.
Mehmet Kanbay, Mustafa C Bulbul, Sidar Copur, Baris Afsar, Alan A Sag, Dimitrie Siriopol, Masanari Kuwabara, Silvia Badarau, Adrian Covic, Alberto Ortiz. J Nephrol 2021
3
100



Blockade of sodium-glucose cotransporter 2 suppresses high glucose-induced angiotensinogen augmentation in renal proximal tubular cells.
Ryousuke Satou, Michael W Cypress, T Cooper Woods, Akemi Katsurada, Courtney M Dugas, Vivian A Fonseca, L Gabriel Navar. Am J Physiol Renal Physiol 2020
9
100



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.